Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,580 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Two different treatment regimens of ranibizumab 0.5 mg for neovascular age-related macular degeneration with or without polypoidal choroidal vasculopathy in Chinese patients: results from the Phase IV, randomized, DRAGON study.
Li X, Zhu Q, Egger A, Chang L, Wolf S, Song Y, Zhang J, Dong F, Xu X, Weisberger A. Li X, et al. Among authors: zhu q. Acta Ophthalmol. 2021 May;99(3):e336-e345. doi: 10.1111/aos.14588. Epub 2020 Dec 30. Acta Ophthalmol. 2021. PMID: 33377611 Free PMC article. Clinical Trial.
Intensified monitoring of circadian blood pressure and heart rate before and after intravitreous injection of bevacizumab: preliminary findings of a pilot study.
Ziemssen F, Zhu Q, Peters S, Grisanti S, El Wardani M, Szurman P, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group; Ziemssen T. Ziemssen F, et al. Among authors: zhu q. Int Ophthalmol. 2009 Aug;29(4):213-24. doi: 10.1007/s10792-008-9221-7. Epub 2008 Apr 17. Int Ophthalmol. 2009. PMID: 18418553
13,580 results
You have reached the last available page of results. Please see the User Guide for more information.